Announce Date | 08/13/2025 |
EPS Normalized Actual | $0.99 (Beat by $0.013) |
EPS GAAP Actual | $0.99 (Beat by $0.013) |
Revenue Actual | $14.673B |
Revenue Surprise | Beat by $14673M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2028 | 4.73 | 14.07 | 4.68285 | 4.82486 | 4 |
Jul 2027 | 0 | INF | 0 | 0 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.71 | 0.71 | 14.673B | 7.03% | 14673M |
FQ2 2025 (Apr 2025) | 0.63 | 0.63 | 14.149B | 10.23% | 14149M |
FQ1 2025 (Jan 2025) | -0.68 | -0.68 | 13.991B | 100% | 13991M |
FQ4 2024 (Oct 2024) | 0.68 | 0.68 | 13.841B | -5.98% | 13841M |
FQ3 2024 (Jul 2024) | 0.54 | 0.54 | 13.642B | -11.44% | 13642M |
FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 12.702B | 100% | 12702M |
FQ1 2024 (Jan 2024) | 0 | 0 | 0B | NAN% | 0M |
FQ4 2023 (Oct 2023) | 0.9 | 0.9 | 14.668B | 100% | 14668M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Jul 2028) | 1.27472 | -- | 1.25078 | 1.29599 | 6 |
FQ2 2028 (Apr 2028) | 1.21557 | -- | 1.19274 | 1.23586 | 6 |
FQ1 2028 (Jan 2028) | 1.12542 | -- | 1.10428 | 1.1442 | 6 |
FQ4 2027 (Oct 2027) | 1.12076 | -- | 1.09971 | 1.13946 | 5 |
FQ3 2027 (Jul 2027) | 1.12173 | -- | 1.11416 | 1.13281 | 9 |
FQ2 2027 (Apr 2027) | 1.07736 | -- | 1.07009 | 1.08801 | 9 |
FQ1 2027 (Jan 2027) | 1.04157 | -- | 1.01319 | 1.05961 | 3 |
FQ4 2026 (Oct 2026) | 1.03192 | -- | 1.01361 | 1.04611 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Jul 2028) | 16.69B | -- | 16.45B | 16.91B | 5 |
FQ2 2028 (Apr 2028) | 16.04B | -- | 15.8B | 16.24B | 5 |
FQ1 2028 (Jan 2028) | 15.38B | -- | 15.15B | 15.57B | 5 |
FQ4 2027 (Oct 2027) | 15.67B | -- | 15.44B | 15.87B | 6 |
FQ3 2027 (Jul 2027) | 15.77B | -- | 15.69B | 15.89B | 9 |
FQ2 2027 (Apr 2027) | 15.27B | -- | 15.19B | 15.38B | 12 |
FQ1 2027 (Jan 2027) | 14.93B | -- | 14.62B | 15.13B | 8 |
FQ4 2026 (Oct 2026) | 14.84B | -- | 14.64B | 15B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | 0.71 | 0.71 | 100% | |
FQ2 2025 (Apr 2025) | 0.63 | 0.63 | 100% | |
FQ1 2025 (Jan 2025) | -0.68 | -0.68 | 100% | |
FQ4 2024 (Oct 2024) | 0.68 | 0.68 | 100% | |
FQ3 2024 (Jul 2024) | 0.54 | 0.54 | 100% | |
FQ2 2024 (Apr 2024) | 0.47 | 0.47 | 100% | |
FQ1 2024 (Jan 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Oct 2023) | 0.9 | 0.9 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0B | $14.67B | $14673M | 100% |
FQ2 2025 (Apr 2025) | $0B | $14.15B | $14149M | 100% |
FQ1 2025 (Jan 2025) | $0B | $13.99B | $13991M | 100% |
FQ4 2024 (Oct 2024) | $0B | $13.84B | $13841M | 100% |
FQ3 2024 (Jul 2024) | $0B | $13.64B | $13642M | 100% |
FQ2 2024 (Apr 2024) | $0B | $12.7B | $12702M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Oct 2023) | $0B | $14.67B | $14668M | 100% |